Zeposia Granted Approval by the European Commission for the Treatment of Multiple Sclerosis
The European Commission has recently granted approval to Bristol Myers Squibb (BMS) for their multiple sclerosis (MS) treatment, Zeposia. It has already been approved by the FDA in the US…